HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

ASIX

AdvanSix Inc. (NYSE)

Basic Materials — Chemicals

AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally. The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. It also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and resins. In addition, the company offers intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines; and cyclohexanol, sulfuric acid, ammonia, and carbon dioxide, as well as automotive components, water treatment, and pharmaceutical intermediates. It offers its products under the Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox under brand names. The company sells its products directly and through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.

Buy 2.0 / 5 2 analysts
$20.29
+$0.44 (+2.22%)
Target: $23.50 (15.8%)
Sign in to add ASIX to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$535.95M
P/E Ratio (TTM)55.22
Forward P/E6.80
EPS (TTM)$0.36
Dividend Yield324.00%
Profit Margin0.67%
Revenue Growth7.00%
ROE1.31%
Debt/Equity53.54
Recommendation Buy 2.0
Analyst Target$23.50
Analysts2
Indexes NYSE

Technical Indicators

RSI (14)37.6
Beta1.29
SMA 20-
SMA 40-
52-Week High$26.73
52-Week Low$14.10
50-Day Avg$22.21
200-Day Avg$19.65
Avg Volume297.8K
Volume213.5K

Performance Analysis

NEUTRAL

ASIX presents a mixed picture with both positive and negative indicators.

~ Trading at 49% of its 52-week range.
~ RSI at 37.6 is in neutral territory.
~ Price dropped below the 50-day average but remains above the 200-day — possible short-term weakness.
- P/E of 55.2 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 7.0% year-over-year.
+ Wall Street consensus is "Buy" from 2 analysts.
+ Average analyst target of $23.50 implies 15.8% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jun 30, 2026 21:07 UTC

Back to Screener Export Report